肺结核患者抗结核药物的不良反应及消除方法

M. Kuzhko, V. Melnyk, М. Gumeniuk, T. Tlustova, T. Sprynsian
{"title":"肺结核患者抗结核药物的不良反应及消除方法","authors":"M. Kuzhko, V. Melnyk, М. Gumeniuk, T. Tlustova, T. Sprynsian","doi":"10.32902/2663-0338-2020-4-13-16","DOIUrl":null,"url":null,"abstract":"ABSTRACT. Here we present the results of retrospective analysis of medical records of 2292 patients with all forms of pulmonary tuberculosis aged 20 to 65 years, who were treated at the National Institute of Tuberculosis and Pulmonology named after F.G. Yanovsky of National Academy of Medical Sciences of Ukraine in 2000-2018. We analyzed the most common side effects of anti-tuberculous drugs and their impact on treatment effectiveness. Practical recommendations for the elimination of adverse reactions to anti-tuberculous drugs in order to increase the effectiveness of treatment of patients with pulmonary tuberculosis are given here.","PeriodicalId":13681,"journal":{"name":"Infusion & Chemotherapy","volume":"2006 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Adverse reactions to anti-tuberculous drugs in patients with pulmonary tuberculosis and ways to eliminate them\",\"authors\":\"M. Kuzhko, V. Melnyk, М. Gumeniuk, T. Tlustova, T. Sprynsian\",\"doi\":\"10.32902/2663-0338-2020-4-13-16\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"ABSTRACT. Here we present the results of retrospective analysis of medical records of 2292 patients with all forms of pulmonary tuberculosis aged 20 to 65 years, who were treated at the National Institute of Tuberculosis and Pulmonology named after F.G. Yanovsky of National Academy of Medical Sciences of Ukraine in 2000-2018. We analyzed the most common side effects of anti-tuberculous drugs and their impact on treatment effectiveness. Practical recommendations for the elimination of adverse reactions to anti-tuberculous drugs in order to increase the effectiveness of treatment of patients with pulmonary tuberculosis are given here.\",\"PeriodicalId\":13681,\"journal\":{\"name\":\"Infusion & Chemotherapy\",\"volume\":\"2006 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-12-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Infusion & Chemotherapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32902/2663-0338-2020-4-13-16\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infusion & Chemotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32902/2663-0338-2020-4-13-16","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

摘要在这里,我们介绍了对2292名年龄在20至65岁之间的各种形式肺结核患者的医疗记录进行回顾性分析的结果,这些患者于2000年至2018年在乌克兰国家医学科学院以F.G. Yanovsky命名的国家结核病和肺病研究所接受治疗。我们分析了抗结核药物最常见的副作用及其对治疗效果的影响。为消除抗结核药物的不良反应,以提高治疗肺结核患者的有效性,这里给出了实用的建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Adverse reactions to anti-tuberculous drugs in patients with pulmonary tuberculosis and ways to eliminate them
ABSTRACT. Here we present the results of retrospective analysis of medical records of 2292 patients with all forms of pulmonary tuberculosis aged 20 to 65 years, who were treated at the National Institute of Tuberculosis and Pulmonology named after F.G. Yanovsky of National Academy of Medical Sciences of Ukraine in 2000-2018. We analyzed the most common side effects of anti-tuberculous drugs and their impact on treatment effectiveness. Practical recommendations for the elimination of adverse reactions to anti-tuberculous drugs in order to increase the effectiveness of treatment of patients with pulmonary tuberculosis are given here.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evaluation of the effectiveness of immunomodulator BI-V in the complex therapy of children and adolescents with multiple drug-resistant pulmonary tuberculosis Features of the course of pulmonary tuberculosis against the background of coronavirus infection according to computed tomography of the chest organs Risks of recurrence in people with pulmonary tuberculosis New and little-known possibilities of edaravone in the treatment of cerebral stroke and extracranial pathology Severe community-acquired pneumonia: principles of diagnostics and intensive therapy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1